NeuroPace, Inc. (NPCE)
14.75
-0.44
(-2.90%)
USD |
NASDAQ |
Sep 03, 16:00
14.72
-0.03
(-0.20%)
After-Hours: 20:00
NeuroPace Research and Development Expense (TTM) : 27.69M for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 27.69M |
| March 31, 2026 | 27.64M |
| December 31, 2025 | 27.89M |
| September 30, 2025 | 26.91M |
| June 30, 2025 | 26.09M |
| March 31, 2025 | 25.31M |
| December 31, 2024 | 23.65M |
| September 30, 2024 | 22.98M |
| June 30, 2024 | 22.02M |
| March 31, 2024 | 21.30M |
| December 31, 2023 | 20.78M |
| September 30, 2023 | 20.49M |
| Date | Value |
|---|---|
| June 30, 2023 | 21.31M |
| March 31, 2023 | 21.63M |
| December 31, 2022 | 21.95M |
| September 30, 2022 | 22.20M |
| June 30, 2022 | 20.92M |
| March 31, 2022 | 19.69M |
| December 31, 2021 | 18.21M |
| September 30, 2021 | 16.78M |
| June 30, 2021 | 16.15M |
| March 31, 2021 | 14.96M |
| December 31, 2020 | 15.70M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Tandem Diabetes Care, Inc. | 186.91M |
| CVRx, Inc. | 12.36M |
| Accuray, Inc. | 37.80M |
| Micron Solutions, Inc. | -- |
| Orthofix Medical, Inc. | 60.33M |